Pulmonx Corp (NQ: LUNG )

37.51 USD +0.21 (+0.56%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 21, 2021 Add to My Watchlist

Price and Volume

Volume	453,862
Open	37.58
Bid (Size)	36.29 (1)
Ask (Size)	46.02 (1)
Prev. Close	37.30
Today's Range	37.11 - 38.13
52wk Range	35.81 - 69.02
Shares Outstanding	36,690,233
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Pulmonx to Present at Upcoming September Investor Conferences

August 26, 2021

Pulmonx Reports Second Quarter 2021 Financial Results

August 03, 2021

Performance

YTD	-37.14%	-37.14%
1 Month	-2.65%	-2.65%
3 Month	-13.25%	-13.25%
6 Month	-30.96%	-30.96%
1 Year	-4.58%	-4.58%

More News

Pulmonx Announces Two Additional Significant Blue Cross Blue Shield Plans Now Provide Coverage for Severe Emphysema/COPD Treatment

Today 16:05 EDT

Pulmonx Welcomes Two New Board Members, Adding Expertise in Health Technology, Consumer Marketing, and Integrated Healthcare Delivery Networks

August 02, 2021

Pulmonx Announces Anthem Blue Cross Blue Shield Now Provides Coverage for Severe COPD/Emphysema Treatment

August 20, 2021

Pulmonx to Present at the Canaccord Genuity 41st Annual Growth Conference

July 29, 2021

Pulmonx to Report Second Quarter 2021 Financial Results on August 3, 2021

July 20, 2021

Pulmonx Announces Long-Term Follow-Up Data Confirming Significant Benefits of Zephyr Valve for Patients with Severe COPD/Emphysema

July 27, 2021

Zephyr® Valve Treatment Provides Long-Term Quality of Life and Lung Function Improvements for Patients with Severe COPD/Emphysema

May 17, 2021

Return on Capital Employed Overview: Pulmonx

August 20, 2021

3 Healthcare Stocks That Might Skyrocket When COVID Is Over

September 07, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.